Skip to main content

Table 5 Multivariate analysis of rs1042522 on survival in 136 patients treated with CHOP or CHOP-like therapy

From: TP53 Arg72 as a favorable prognostic factor for Chinese diffuse large B-cell lymphoma patients treated with CHOP

Variable Hazard ratio 95% CIs P
GCB/Non-GCB 0.316 0.158–0.633 0.001
IPI score 4.218 2.235–7.962 0.000
GG + GC/CC 0.343 0.173–0.679 0.002